The Federal Antimonopoly Service of the Russian Federation plans to review the format and improve the list of vital and essential drugs (VED). This, Messages sections.
“Creation and care (of the list – socialbites.ca) should be carried out according to the groups of dosage forms combined by the method of application and administration. Based on the proposals of the anti-monopoly department, the Ministry of Health of the Russian Federation prepared a number of amendments to the decree of the Government of the Russian Federation on the establishment of a list of vital and essential drugs. says message.
In 2022, at the initiative of the Federal Antimonopoly Service, 35 dosage forms equivalent to previously listed drugs were added to the list. According to the agency, expanding this mechanism will contribute to the development of a competitive environment in drug circulation markets and prevent unreasonable circumvention of price regulation requirements.
Former Russian President Vladimir Putin instructed The Government of the Russian Federation will consider the issue of state support to pharmaceutical manufacturers by April 1. The instruction was given to avoid drug shortages due to the risk of foreign pharmaceutical companies leaving the Russian market.
Earlier, the press service of Roszdravnadzor stated that drugs in the List of Vital and Essential Medicines increased by 0.5% in January-February 2023, which is comparable to the same indicator in 2022.